Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Financing Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr

What is the latest Cash Flow from Financing Activities ratio of BIOCON ?

The latest Cash Flow from Financing Activities ratio of BIOCON is ₹-1,854 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1,854 Cr
Mar2024₹-2,333 Cr
Mar2023₹13,049 Cr
Mar2022₹242 Cr
Mar2021₹2,564 Cr

How is Cash Flow from Financing Activities of BIOCON Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1,854 Cr
Negative
Mar2024 ₹-2,333 Cr
Negative
Mar2023 ₹13,049 Cr
5,289.80
Mar2022 ₹242 Cr
-90.56
Mar2021 ₹2,564 Cr -

Compare Cash Flow from Financing Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹58,060.6 Cr 2.8% -6.5% 14.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

2.8%

-6.5%

14.9%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses